The nonparametric bootstrapping analysis showed that the 95% CIs for ICERs were in a range of US$54,391 to US$231,475 ( US$70,894 to $37,945) for all-cause death and US$28,870 to US$122,865 ( S$37,630 to US$20,141) for hospitalized hypoglycemia from the payer perspective (healthcare sector perspective)
Your Healthspan membership covers clinical oversight and a care model designed to support safe, effective GLP-1 use over time
Experimental Dermatology
Melanoma develops from melanocytes, the same cells MT-2 stimulates
While panic attacks are not dangerous in themselves, the symptoms overlap with cardiac events that are dangerous
Patients taking GLP-1 agonists most commonly complain of gastrointestinal effects, 2 such as unsettled stomach, upset GI tract, variable bowel movements or trouble with elimination, abdominal discomfort, and gastroesophageal discomfort